Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Compassion use trial of PN 27.1 in prostate cancer patients underway

May 10, 1996

Hybridon will file IND for antisense PKA down-regulator

May 10, 1996

SunPharm to test DEHOP in cancer patients

May 10, 1996

Oncolysin B effective in tumor models in mice; phase II trials underway

May 10, 1996

Agouron reports phase II data for Thymitaq

May 3, 1996

Hybridon reports oligonucleotide MDR inhibitors

May 3, 1996

Vertex dedicates significant efforts to MDR-reversing agents

May 3, 1996

Receptagen will develop vitamin B12 uptake inhibitors

May 3, 1996

Somatix receives patent protection for novel glioma treatment

May 3, 1996

NSAID blocks carcinogenesis in rodent models

May 3, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
First phase of synthetic human genome project successfully completes
BioWorld
The first phase of the U.K. synthetic human genome project has successfully completed, realizing key steps in chromosome synthesis. The work has demonstrated a...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Laigo raises €11.5M seed money for targeted protein degradation
BioWorld Science
Laigo Bio BV has raised €11.5 million (US$13.7 million) in a seed round for the further development of a new approach to inducing targeted protein degradation by...